Juan José Ortiz de Urbina González-rekin lankidetzan egindako argitalpenak (1)
2024
-
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345